Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-21-113568
Filing Date
2021-09-08
Accepted
2021-09-08 06:01:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a21-27096_1sc13da.htm SC 13D/A 60428
  Complete submission text file 0001104659-21-113568.txt   61594
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Subject) CIK: 0001574232 (see all company filings)

EIN.: 000000000
Type: SC 13D/A | Act: 34 | File No.: 005-91805 | Film No.: 211240588
SIC: 2834 Pharmaceutical Preparations

Mailing Address CHEMIN DES MINES 9 CH-1202 GENEVA V8 CH-1202
Business Address
Dyer Timothy Mark (Filed by) CIK: 0001830908 (see all company filings)

Type: SC 13D/A